Reference Scale Average Bioequivalence Approach: ANVISA, Brazil [Regulatives / Guidelines]

posted by Maitri – India, 2018-09-21 19:49 (1046 d 23:46 ago) – Posting: # 19297
Views: 1,884

Hello,

Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compounds?

Thanks & Regards,
Maitri Sanghavi

Complete thread:

Activity
 Admin contact
21,606 posts in 4,517 threads, 1,532 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Tuesday 19:36 CEST (Europe/Vienna)

There are no routine statistical questions,
only questionable statistical routines.    David R. Cox

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5